Recent News
Powered by Alpha Vantage
No recent news found.
AI Tools
Key Metrics
Trend: Downtrend
Source: Snapshot
Qilian International Holding Group Limited manufactures and distributes active pharmaceutical ingredients (APIs), traditional Chinese medicine derivatives (TCMD), and other by-products in China. The company is headquartered in Jiuquan, the People's Republic of China.
52W High
$17.17
52W Low
$6.06
MA Status:
50D: Below
200D: Below
Beta (~1 neutral, <0.9 lower risk)
1.46
Valuation
As of 2024-03-31 (Overview)
Trailing P/E (<15 better)
N/A
Forward P/E (<15 better)
N/A
EV/EBITDA (<8 favorable)
-2.48
EV/Revenue (<3 favorable)
53.70
P/S (TTM) (<3 favorable)
48.69
P/B (<3 favorable)
7.99
Ownership
Retail‑heavySource: Overview
Insiders (1–5% typical)
7.29%
Institutions (25–75% balanced)
0.00%
Shares Outstanding
180,623,000
Float
2,832,600
Dividend Yield (2–6% sweet spot)
N/A
Ex‑Dividend Date
2023-02-27
Income & Growth
Profitability: Weak
As of 2024-03-31 (Overview)
Revenue (TTM)
29,870,500
Gross Profit (TTM)
870,770
EPS (TTM)
-0.29
Profit Margin (>10% good)
-0.26%
Operating Margin (TTM) (higher better)
-0.05%
ROE (TTM) (>15% strong)
-0.17%
EPS YoY (Quarterly) (>10% good)
N/A
Revenue YoY (Quarterly) (>8% good)
-0.57
Momentum
Bearish momentumValue
-0.3842
Previous
-0.3998
Trend
Rising
Signal Cross
No cross
As of
Sep. 12, 2025